Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07647250 · ClinicalTrials.gov registry record · NA
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
A NA study, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07647250: Recruiting NA study, sponsored by University of Illinois at Chicago.
NCT07647250 is a NA study that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07647250, a NA study, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Primary Outcome
Defined as the number of participants enrolled divided by the number of eligible patients approached.
Interventions
- OTHER 36-session targeted physical exercise program delivered twice weekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-22 |
| Est. Completion | 2032-04-30 |
| Phase | NA |
What NCT07647250 shows while recruiting
NCT07647250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which 36-session targeted physical exercise program delivered twice weekly is the first listed.
NCT07647250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07647250 about?
NCT07647250 is a clinical study titled "Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy". Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
What is the current status of trial NCT07647250?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-06-22. Estimated completion is 2032-04-30.
What interventions are being tested in trial NCT07647250?
The interventions under investigation include: 36-session targeted physical exercise program delivered twice weekly (OTHER).
Who is sponsoring clinical trial NCT07647250?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07647250's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI